Trending...
- City of Spokane Launches New Webpage, Notice Document to Connect Residents with Eviction Prevention Resources
- Tacoma: Homicide Investigation – 800 Block of Martin Luther King JR Way
- City of Tacoma Attracts More Affordable Housing to Proctor Neighborhood
Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.
RESEARCH TRIANGLE PARK, N.C. - Washingtoner -- Elixia proudly welcomes Sam Searcy as the company's Chief Commercial Officer. Searcy will oversee activities related to marketing, enhance service offerings, expand Elixia's national site network, maintain client customer service, strategize Elixia's business growth, and increase Elixia's overall market share. Searcy will also manage Elixia's RTP office and the N.C.-based operations team.
"I am thrilled to have the opportunity to work with such a talented team. Elixia is truly implementing a breakthrough approach to clinical trials" Sam Searcy, CCO Searcy joins Elixia as an influential business and community leader with over 10 years of executive leadership roles in small and medium-sized companies in the life science sector. Searcy has a proven track record of building strong, efficient, and productive executive teams, and launching industry-disrupting products and services. Searcy also focuses on community as he serves on a number of corporate and volunteer Boards, including the N.C. Community College System, Appalachian State University Board of Visitors and ICE Global Consulting. He also serves as a Senior Advisor to NeuroVice, a Triangle-based medical device company focused on the medical needs of patients with various seizure disorders.
More on Washingtoner
"We are excited to have Sam join the Elixia team. Sam's years of experience in life sciences will help Elixia navigate our current period of rapid growth." Neal Patel, CEO. The addition of Searcy will add value to the Elixia team, accelerate the company's goals, and support Elixia's overall mission.
About Elixia
Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health, and Infectious disease trials. Elixia's mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. Elixia maintains corporate headquarters in Palm Beach FL, and the Research Triangle Park.
"I am thrilled to have the opportunity to work with such a talented team. Elixia is truly implementing a breakthrough approach to clinical trials" Sam Searcy, CCO Searcy joins Elixia as an influential business and community leader with over 10 years of executive leadership roles in small and medium-sized companies in the life science sector. Searcy has a proven track record of building strong, efficient, and productive executive teams, and launching industry-disrupting products and services. Searcy also focuses on community as he serves on a number of corporate and volunteer Boards, including the N.C. Community College System, Appalachian State University Board of Visitors and ICE Global Consulting. He also serves as a Senior Advisor to NeuroVice, a Triangle-based medical device company focused on the medical needs of patients with various seizure disorders.
More on Washingtoner
- Allstream Energy Partners Announced as Official Media Partner for the 2nd Annual Permian Power Conference
- ATTENTION: DGCA India & CAAC China — Boeing Quality Chief Doug Ackerman Linked To 24 Year Unaccredited Manufacturing Gap Ahead Of 787 Failures
- City of Tacoma to Implement Temporary Road Closures and Traffic Restrictions on June 12
- Spokane: Notice from SPD as Team Egypt Arrives & FIFA Events Begin
- Spokane: Significant Impacts to North-South Travel
"We are excited to have Sam join the Elixia team. Sam's years of experience in life sciences will help Elixia navigate our current period of rapid growth." Neal Patel, CEO. The addition of Searcy will add value to the Elixia team, accelerate the company's goals, and support Elixia's overall mission.
About Elixia
Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health, and Infectious disease trials. Elixia's mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. Elixia maintains corporate headquarters in Palm Beach FL, and the Research Triangle Park.
Source: Elixia
0 Comments
Latest on Washingtoner
- A Foundational Claim in Human Secrecy Goes Public
- Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
- Las Vegas Headliner Don Barnhart Brings National Touring Comedy Show to Comedy Cabana
- Nevada Boxing Hall of Fame Announces 14th Annual Induction Gala Weekend Honoring Classes of 2025 and 2026
- Brosix Celebrates 20 Years of Private Team Messaging for Small and Mid-Sized Businesses
- Top 15 Mosquito-Infested Cities in Louisiana and East Texas Ranked for 2026 Mosquito Season
- From Broken to Soaring Week 40
- Tacoma Dome Welcomes Class of 2026
- Finnish Political Satire Film Generates 10,000+ Cross-Platform Interactions Following Gandalf Parody Video Across TikTok, YouTube and Telegram
- City of Tacoma Launches 'Tidy-Up Tacoma: Summer 2026' With Major Gateway Cleanup Effort
- Grady Bay Capital Completes Acquisition of Brickhouse GPS
- AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
- 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
- netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
- Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent
- Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
- Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
- $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
- City of Tacoma Attracts More Affordable Housing to Proctor Neighborhood
- Tacoma: Homicide Investigation – 800 Block of Martin Luther King JR Way
